Effective July 1, 2026, Dani Bendheim will assume the role of President and Chief Executive Officer (CEO) of Phibro Animal Health Corporation.
Jack Bendheim will transition to Executive Chairman and continue serving as Chairman of the Board of Directors.
Phibro stated that this leadership transition supports the company’s continued growth and long-term strategic direction.
Dani Bendheim has been a part of Phibro since 1997 and currently serves as Executive Vice President, Corporate Strategy.
Throughout his tenure, he has played an important role in helping shape the company’s strategic growth, operational focus and long-term vision.
His leadership has supported the continued expansion of Phibro’s global presence and commitment to delivering science-based solutions for customers around the world.
As Phibro enters its next chapter, the company remains focused on advancing animal health and nutrition through innovation, collaboration and long-term partnership.